| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Benevich Eric is a Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $8.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2019 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 920 | $83.57 | $76,883.02 | -4.2% | |
| Feb 5, 2019 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,357 | $88.01 | $119,426.71 | -3.6% | |
| Jun 1, 2018 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 12,350 | $97.34 | $1,202,163.82 | -42.5% | |
| Feb 5, 2018 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 820 | $83.14 | $68,174.23 | -24.1% | |
| Feb 7, 2017 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 953 | $43.32 | $41,287.11 | -43.8% |